1. Home
  2. CCO vs PGEN Comparison

CCO vs PGEN Comparison

Compare CCO & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.41

Market Cap

1.2B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.63

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCO
PGEN
Founded
1995
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
CCO
PGEN
Price
$2.41
$3.63
Analyst Decision
Hold
Buy
Analyst Count
5
5
Target Price
$2.12
$8.33
AVG Volume (30 Days)
4.7M
4.5M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
110.81
N/A
EPS
N/A
N/A
Revenue
$1,604,140,000.00
$230,981,000.00
Revenue This Year
$5.35
$1,115.92
Revenue Next Year
$4.26
$81.04
P/E Ratio
N/A
N/A
Revenue Growth
6.57
N/A
52 Week Low
$1.00
$1.38
52 Week High
$2.43
$5.47

Technical Indicators

Market Signals
Indicator
CCO
PGEN
Relative Strength Index (RSI) 59.52 38.10
Support Level $2.37 $3.49
Resistance Level $2.41 $4.40
Average True Range (ATR) 0.01 0.24
MACD 0.00 -0.09
Stochastic Oscillator 100.00 12.40

Price Performance

Historical Comparison
CCO
PGEN

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: